Arrowhead Pharmaceuticals, Inc.
Overview
Arrowhead Pharmaceuticals, Inc. is a biotechnology company focused on developing RNA interference (RNAi) therapeutics for the treatment of intractable diseases by silencing the genes that cause them. The company's proprietary Targeted RNAi Molecule (TRiM) platform is designed to enable tissue-specific delivery of RNAi therapeutics.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Arrowhead Pharmaceuticals, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Related companies
Ionis Pharmaceuticals, Inc.
United States
Otsuka Pharmaceutical Development & Commercialization, Inc.
United States
ZS Pharma, Inc.
United States
AstraZeneca do Brasil Ltda.
Brazil
AstraZeneca İlaç Sanayi ve Ticaret Limited Şirketi
Turkey
Abbott Laboratories
USA
ABC Biopharmaceuticals, Inc.
United States
ABX Pharmaceuticals Inc.
USA
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.